SEARCH

SEARCH BY CITATION

References

  • 1
    Richardson, P.D., Kren, B.T. & Steer, C.J. (2001) Targeted gene correction strategies. Curr. Opin. Mol. Ther. 3, 14648431.
  • 2
    Ye, S., Cole-Strauss, A.C., Frank, B. & Kmiec, E.B. (1998) Targeted gene correction: a new strategy for molecular medicine. Mol. Med. Today 4, 431437.
  • 3
    Inoue, H., Hayase, Y., Iwai, S. & Ohtsuka, E. (1987) Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett. 215, 327330.
  • 4
    Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. & Freier, S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268, 1451414522.
  • 5
    Yoon, K., Cole-Strauss, A. & Kmiec, E.B. (1996) Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide. Proc. Natl Acad. Sci. USA 93, 20712076.
  • 6
    Lai, L.W. & Lien, Y.H. (2002) Chimeric RNA/DNA oligonucleotide-based gene therapy. Kidney Int. 61, 4751.
  • 7
    Parekh-Olmedo, H., Czymmek, K. & Kmiec, E.B. (2001) Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors. Sci. STKE 13, PL1.
  • 8
    Lai, L.W. & Lien, Y.H. (2001) Therapeutic application of chimeric RNA/DNA oligonucleotide based gene therapy. Expert Opin. Biol. Ther. 1, 4147.
  • 9
    Lebedeva, I., Benimetskaya, L., Stein, C.A., & Vilenchik, M. (2000) Cellular delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 50, 101109.
  • 10
    Gamper, H.B., Parekh, H., Rice, M.C., Bruner, M., Youkey, H. & Kmiec, E.B. (2000) The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. Nucleic Acids Res. 28, 43324339.
  • 11
    Cole-Strass, A., Yoon, K., Xiang, Y., Byrne, B.C., Rice, M.C., Gryn, J., Holloman, W.K. & Kmiec, E.B. (1996) Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 273, 13861389.
  • 12
    Wu, X.S., Liu, D.P. & Liang, C.C. (2001) Prospects of chimeric RNA-DNA oligonucleotides in gene therapy. J. Biomed. Sci. 8, 439445.
  • 13
    Rice, M.C., Czymmek, K. & Kmiec, E.B. (2001) The potential of nucleic acid repair in functional genomics. Nat Biotechnol. 19, 321326.
  • 14
    Lai, L.W. & Lien, Y.H. (2002) Chimeric RNA/DNA oligonucleotide-based gene therapy. Kidney Int. 61 (Suppl. 1), 4751.
  • 15
    Bertoni, C. & Rando, T.A. (2002) Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum. Gene Ther. 13, 707718.
  • 16
    Graham, I.R. & Dickson, G. (2002) Gene repair and mutagenesis mediated by chimeric RNA-DNA oligonucleotides: chimeraplasty for gene therapy and conversion of single nucleotide polymorphisms (SNPs). Biochim. Biophys. Acta 1587, 16.
  • 17
    Kren, B.T., Chen, Z., Felsheim, R., Roy Chowdhury, N., Roy Chowdhury, J. & Steer, C.J. (2002) Modification of hepatic genomic DNA using RNA/DNA oligonucleotides. Gene Ther. 9, 686690.
  • 18
    Liang, E., Ajmani, P.S. & Hughes, J.A. (1999) Oligonucleotide delivery: a cellular prospective. Pharmazie 54, 559566.
  • 19
    Godbey, W.T. & Mikos, A.G. (2001) Recent progress in gene delivery using non-viral transfer complexes. J. Control Release 72, 115125.
  • 20
    Cheung, C.Y., Murthy, N., Stayton, P.S. & Hoffman, A.S. (2001) A PH-Sensitive Polymer That Enhances Cationic Lipid-Mediated Gene Transfer. Bioconjug. Chem. 12, 906910.
  • 21
    Hughes, M.D., Hussain, M., Nawaz, Q., Sayyed, P. & Akhtar, S. (2001) The cellular delivery of antisense oligonucleotides and ribozymes. Drug Discov. Today 6, 303315.
  • 22
    Li, Z.H., Liu, D.P., Yin, W.X., Guo, Z.C. & Liang, C.C. (2001) Targeted correction of the point mutations of β-thalassemia and targeted muatagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: potential for β-thalassemia gene therapy. Blood Cells Mol. Dis. 27, 530538.
  • 23
    Godbey, W.T., Wu, K.K., & Mikos, A.G. (1999) Poly (ethylenimine) and its role in gene delivery. J. Control Release 60, 149160.
  • 24
    De Semir, D., Petriz, J., Avinyo, A., Larriba, S., Nunes, V., Casals, T., Estivill, X. & Aran, J.M. (2002) Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells. J. Gene Med. 4, 308322.
  • 25
    Bandyopadhyay, P., Ma, X., Linehan-Stieers, C., Kren, B.T. & Steer, C.J. (1999) Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor. J. Biol. Chem. 274, 1016310172.
  • 26
    Kren, B.T., Metz, R., Kumar, R. & Steer, C. (1999) Gene repair using chimeric RNA/DNA oligonucleotides. J. Semin. Liver Dis. 19, 93104.
  • 27
    Kren, B.T., Bandyopadhyay, P. & Steer, C.J. (1998) In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat. Med. 4, 285290.
  • 28
    Kren, B.T., Parashar, B., Bandyopadhyay, P., Chowdhury, N.R., Chowdhury, J.R. & Steer, C.J. (1999) Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler–najjar syndrome type I with a chimeric oligonucleotide. Proc. Natl Acad. Sci. USA 96, 1034910354.
  • 29
    Welz, C., Neuhuber, W., Schreier, H., Repp, R., Rascher, W. & Fahr, A. (2000) Nuclear gene targeting using negatively charged liposomes. Int. J. Pharm. 196, 251252.
  • 30
    Liu, L., Rice, M.C. & Kmiec, E.B. (2001) In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res. 29, 42384250.
  • 31
    Santiago, F.S., Lowe, H.C., Kavurma, M.M., Chesterman, C.N., Baker, A., Atkins, D.G. & Khachigian, L.M. (1999) New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med. 5, 12641269.
  • 32
    Villa, A.E., Guzman, L.A., Poptic, E.J., Labhasetwar, V., D'Souza, S., Farrell, C.L., Plow, E.F., Levy, R.J., DiCorleto, P.E. & Topol, E.J. (1995) Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ. Res. 76, 505513.
  • 33
    Borchard, G. (2001) Chitosans for gene delivery. Adv. Drug. Deliv. Rev. 52, 14550.
  • 34
    Koping-Hoggard, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Varum, K.M. & Artursson, P. (2001) Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8, 11081121.
  • 35
    Sato, T., Ishii, T. & Okahata, Y. (2001) In vitro gene delivery mediated by chitosan effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22, 20752080.
  • 36
    Lee, K.Y., Kwon, I.C., Kim, Y.H., Jo, W.H. & Jeong, S.Y. (1998) Preparation of chitosan self- aggregates as a gene delivery system. J. Control Release 51, 213220.
  • 37
    Erbacher, P., Zou, S., Bettinger, T., Steffan, A.M. & Remy, J.S. (1998) Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 15, 13321339.
  • 38
    Bernkop-Schnurch, A. & Kast, C.E. (2001) Chemically modified chitosans as enzyme inhibitors. Adv. Drug Deliv. Rev. 52, 127137.
  • 39
    Lambert, G., Fattal, E. & Couvreur, P. (2001) Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv. Drug. Deliv. Rev. 47, 99112.
  • 40
    Aynie, I., Vauthier, C., Chacun, H., Fattal, E. & Couvreur, P. (1999) Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 9, 301312.
  • 41
    Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A. & Couvreur, P. (2001) Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. Int. J. Pharm. 214, 1316.
  • 42
    Gorlich, D. & Mattaj, I.W. (1996) Nucleocytoplasmic transport. Science 271, 15131518.
  • 43
    Aanta, M.A., Belguise-Valladier, P. & Behr, J.P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl Acad. Sci. USA 96, 9196.
  • 44
    Vacik, J., Dean, B.S., Zimmer, W.E. & Dean, D.A. (1996) Cell-specific nuclear import of plasmid DNA. Gene Ther. 6, 10061014.
  • 45
    Chen, Z., Felsheim, R., Wong, P., Augustin, L.B., Metz, R., Kren, B.T. & Steer, C.J. (2001) Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair. Biochem. Biophys. Res. Commun. 285, 188194.
  • 46
    Weissig, V. & Torchilin, V.P. (2001) Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. Adv. Drug. Deliv. Rev. 49, 127149.
  • 47
    Lander, E.S. & Lodish, H. (1990) Mitochondrial diseases: gene mapping and gene therapy. Cell 61, 925926.
  • 48
    Seibel, P., Trappe, J., Villani, G., Klostock, T., Papa, S. & Reichmann, H. (1995) Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res. 23, 1017.